Interleukin-7 levels may predict virological response in advanced HIV-1-infected patients receiving lopinavir/ritonavir-based therapy

This publication has 17 references indexed in Scilit:

• Lopinavir–Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection
  New England Journal of Medicine, 2002
• Safety and Antiviral Activity at 48 Weeks of Lopinavir/Ritonavir plus Nevirapine and 2 Nucleoside Reverse‐Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1–Infected Protease Inhibitor–Experienced Patients
  The Journal of Infectious Diseases, 2002
• Interleukin-7 Receptor Expression on CD8 + T Cells Is Reduced in HIV Infection and Partially Restored With Effective Antiretroviral Therapy
  JAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
• Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac−2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy
  Clinical and Experimental Immunology, 2001
• Interleukin-7 in Plasma Correlates with CD4 T-Cell Depletion and May Be Associated with Emergence of Syncytium-Inducing Variants in Human Immunodeficiency Virus Type 1-Positive Individuals
  Journal of Virology, 2001
• A potential role for interleukin-7 in T-cell homeostasis
  Blood, 2001
• Influence of Age on CD4 Cell Recovery in Human Immunodeficiency Virus–Infected Patients Receiving Highly Active Antiretroviral Therapy: Evidence from the EuroSIDA Study
  The Journal of Infectious Diseases, 2001
• Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis
  Nature Medicine, 2001
• Immune Restoration With Antiretroviral Therapies
  Published by American Medical Association (AMA) ,2000
• Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count
  Bone Marrow Transplantation, 1999